Safety and clinical activity of durvalumab monotherapy in patients with hepatocellular carcinoma (HCC) Meeting Abstract
| Authors: | Wainberg, Z. A.; Segal, N. H.; Jaeger, D.; Lee, K. H.; Marshall, J.; Antonia, S. J.; Butler, M.; Sanborn, R. E.; Nemunaitis, J. J.; Carlson, C. A.; Finn, R. S.; Jin, X.; Antal, J.; Gupta, A. K.; Massard, C. |
| Abstract Title: | Safety and clinical activity of durvalumab monotherapy in patients with hepatocellular carcinoma (HCC) |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 216s |
| Language: | English |
| ACCESSION: | WOS:000411895708155 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.4071 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4071 -- Source: Wos |
